| Announce Date | 11/25/2025 |
| EPS Normalized Actual | $0.4294 (Miss by $-0.1406) |
| EPS GAAP Actual | $0.4294 (Miss by $-0.1406) |
| Revenue Actual | $0.186132B |
| Revenue Surprise | Beat by $186.132M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $0.2075B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2028 | 1.87 | 13.24 | 1.85741 | 1.88258 | 1 |
| Jan 2027 | 3.44 | 7.19 | 3.42966 | 3.45034 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.43 | 0.43 | 0.186132B | 1.83% | -16.87M |
| FQ3 2025 (Jul 2025) | 0.13 | 0.13 | 0.161829B | 1.55% | -11.67M |
| FQ2 2025 (Apr 2025) | 0.06 | 0.06 | 0.131769B | -3.72% | -23.43M |
| FQ1 2025 (Jan 2025) | 0.36 | 0.36 | 0.181475B | 1.02% | -16.13M |
| FQ4 2024 (Oct 2024) | -0.29 | -1.82737 | 0.182727B | -2.71% | -10.57M |
| FQ3 2024 (Jul 2024) | 0.16 | -1.17835 | 0.159313B | -0.68% | -161.47M |
| FQ2 2024 (Apr 2024) | 0.13 | 0.13 | 0.136669B | -6.03% | 136.67M |
| FQ1 2024 (Jan 2024) | 0.55 | 0.55 | 0.17962B | -8.16% | 179.62M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.2075B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 0 | -- | 0 | 0 | 0 |
| FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (Apr 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Oct 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ3 2026 (Jul 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ2 2026 (Apr 2026) | 0 | -INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 0.19B | -- | 0.19B | 0.19B | 1 |
| FQ3 2027 (Jul 2027) | 0.17B | -- | 0.17B | 0.17B | 1 |
| FQ2 2027 (Apr 2027) | 0.14B | -- | 0.14B | 0.14B | 1 |
| FQ4 2026 (Oct 2026) | 0.18B | -0.92 | 0.18B | 0.18B | 1 |
| FQ3 2026 (Jul 2026) | 0.16B | -2.87 | 0.16B | 0.16B | 1 |
| FQ2 2026 (Apr 2026) | 0.14B | 2.74 | 0.14B | 0.14B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
2
Revenue # of Misses
6
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0 | 0.43 | 0.43 | 100% |
| FQ3 2025 (Jul 2025) | 0 | 0.13 | 0.13 | 100% |
| FQ2 2025 (Apr 2025) | 0 | 0.06 | 0.06 | 100% |
| FQ1 2025 (Jan 2025) | 0 | 0.36 | 0.36 | 100% |
| FQ4 2024 (Oct 2024) | 1.53737 | -0.29 | -1.82737 | 630.13% |
| FQ3 2024 (Jul 2024) | 1.33835 | 0.16 | -1.17835 | -736.47% |
| FQ2 2024 (Apr 2024) | 0.13 | 0.13 | 100% | |
| FQ1 2024 (Jan 2024) | 0.55 | 0.55 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.2B | $0.19B | $-16.87M | -9.06% |
| FQ3 2025 (Jul 2025) | $0.17B | $0.16B | $-11.67M | -7.21% |
| FQ2 2025 (Apr 2025) | $0.16B | $0.13B | $-23.43M | -17.78% |
| FQ1 2025 (Jan 2025) | $0.2B | $0.18B | $-16.13M | -8.89% |
| FQ4 2024 (Oct 2024) | $0.19B | $0.18B | $-10.57M | -5.79% |
| FQ3 2024 (Jul 2024) | $0.32B | $0.16B | $-161.47M | -101.35% |
| FQ2 2024 (Apr 2024) | $0B | $0.14B | $136.67M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.18B | $179.62M | 100% |